DEBx Medical joined partnership with NBIC

We are happy to announce that DEBx Medical has joined the network of the National Biofilm Innovation Centre (NBIC) of the United Kingdom as an industrial partner. The NBIC exists to create a fusion of world class interdisciplinary research and industry partnerships to deliver breakthrough science and technologies to control and exploit biofilms.

After having several (digital) conversations with their CEO, Mark Richardson, the NBIC and DEBx Medical are now looking for potential scientific partners at three top universities in the UK that are currently researching the formation and development of biofilms in wounds. Together we will further substantiate the effectiveness of our product against microorganisms such as mixed strains of bacteria, fungi, viruses, algae, microbes, and other cellular debris inside Biofilms.

Any suggestions or opportunities that you would like to inform us about? Let us know!

More Posts

In Depth: Debridement

The presence of a biofilm in a wound is known to be detrimental to wound healing as is the case with the presence of necrosis

In Depth: Biofilms

Virtually all wounds contain bacteria but the type and number of bacteria, their phenotype, as well as the way they are organized determine to what

DEBx Medical Opens Office in US

Exiting things are happening at DEBx Medical, and we want to share some important news with you. We are proud to announce that, despite the

Biofilms and Antibiotic Resistance

In these times of fewer conventions, congresses, and scientific meetings the world is luckily still continuing scientific research and publishing their results. A group of

Get in touch

welcome.

Login to get access to our case reports.

im_debx-medical_logo

Login to your account